Acamprosate prevents relapse to drinking in alcoholism
2010-09-08
(Press-News.org) Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new Cochrane Systematic Review. The drug showed moderate benefits in trials when used in addition to non-drug treatments.
Drinking too much alcohol increases the risk of ill health. According to the World Health Organization, alcohol misuse is at the root of around a quarter of all cases of oesophageal cancer, liver disease and epilepsy, as well as road accidents and homicides. Acamprosate and naltrexone are drugs used alongside psychosocial methods to help prevent relapse in alcoholics who are trying to stop drinking.
The researchers reviewed data from 24 randomised controlled trials, considered the gold standard for clinical studies. Altogether these trials involved 6,915 alcohol dependent patients who were also undergoing psychosocial therapies. Acamprosate prevented relapse in one in every nine patients who had stopped drinking and increased the number of days patients spent not drinking by an average of three days a month. The researchers showed that the risk of a patient on acamprosate returning to drinking was 86% of that of a patient who took a placebo instead. Diarrhoea was the only side effect that was more frequently reported under acamprosate than placebo.
"Acamprosate is certainly no magic bullet, but it is a safe and effective treatment for patients who are trying to stop drinking," said lead researcher Susanne Rösner of the Psychiatric Hospital at the University of Munich, Germany. "The benefits we have seen in these trials are small. However, we must remember that these are additional benefits on top of those from other non-drug therapies."
The researchers stress the need to respect a patient's right to choose by providing all the necessary information about the benefits and drawbacks of the drugs when recommending a therapeutic strategy. "Patients' doubts and reservations against a strategy that uses one substance to treat dependency on another should be taken seriously, while interventions that have been shown to work should not kept back from patients," said Rösner.
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2010-09-08
Microbes could be threatening our cultural heritage by degrading historic cinematographic film and even preventing some valuable footage to be archived at all.
Mr Gavin Bingley who is presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today describes how fungal growth on cinema film can not only lead to deterioration of the film but may also pose a risk to the archivist.
"Fungi that form mould on film reels produce enzymes that enable them to use components of the film for growth, leading to degradation of the film," explained ...
2010-09-08
There are currently no reliably safe and effective treatments for morning sickness, according to Cochrane researchers who conducted a systematic review of the available evidence. There was very limited evidence for all pharmaceutical and alternative medicines tested.
Morning sickness is the term used to describe vomiting and feelings of nausea in pregnant women. Symptoms can in fact occur at any time of the day and affect more than half of all women in the early stages of pregnancy. Due to concerns that pharmaceutical medicines may damage their unborn children, women ...
2010-09-08
The likelihood that the treatment of a middle ear infection will fail is slightly higher for a child who is given a shorter course of antibiotics, according to a new Cochrane Systematic Review. The results are conclusive, but the researchers say there are other factors that must be considered when the drugs are prescribed.
Most children suffer at some point from a middle ear infection, also called acute otitis media (AOM). It is one of the most common reasons for children being prescribed antibiotics, at a cost of up to $5 billion each year in the US alone. Health practitioners ...
2010-09-08
HIV-infected children in South Africa who were exposed to the drug nevirapine at birth (used to help prevent mother-to-child HIV transmission) and then received a protease inhibitor (PI) for viral suppression achieved lower rates of viremia (virus in the blood stream) if they were switched to nevirapine, compared to children who continued on the PI-based regimen, according to a study in the September 8 issue of JAMA. PI-based therapies generally have a higher cost compared to nevirapine, which may leave some children excluded from treatment.
Current guidelines for nevirapine-exposed ...
2010-09-08
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
"Pancreatic cancer is one of the major causes of cancer death globally, with a 5-year survival rate of less than 5 percent. The outlook for those patients who can undergo surgical resection is better, ...
2010-09-08
Two new studies have shed more light on how smoking may damage fertility, and give further weight to advice that mothers and fathers-to-be should stop smoking before attempting to conceive. The research is published online in Europe's leading reproductive medicine journal Human Reproduction today (Wednesday 8 September).
In the first study [1], researchers found that a mother's smoking during early pregnancy dramatically reduces the numbers of germ cells (the cells that form eggs in females and sperm in males) and somatic cells (the cells that form every other part of ...
2010-09-08
An international consortium of researchers has completed the majority of the genome sequence of the domesticated turkey, thanks in part to the efforts of Virginia Tech faculty members.
The research team will publish "Multi-Platform Next-Generation Sequencing of the Domestic Turkey (Meleagris gallopavo): Genome Assembly and Analysis" in the journal PLoS Biology (Public Library of Science) on Sept. 7, 2010.
"To date, more than 90 percent of the domesticated turkey genome has been sequenced and assembled," said Rami Dalloul, assistant professor of animal and poultry sciences ...
2010-09-08
The Potomac River in Washington, D.C. is showing multiple benefits from restoration efforts, newly published research suggests. Reduced nutrients and improved water clarity have increased the abundance and diversity of submerged aquatic vegetation (SAV) in the Potomac, according to direct measurements taken during the 18-year field study.
Since 1990, the area covered by SAV in the lower Potomac has doubled, the area covered by native SAV has increased ten-fold, the diversity of plant species has increased, and the proportion of exotic species to native species has declined ...
2010-09-08
Uncovering the secrets of the brain requires an intense network of collaborative research. Building on a tool that was co-developed in his laboratory and described in a recent issue of Brain, Dr. Yaniv Assaf of Tel Aviv University's Department of Neurobiology is collaborating with an international team of scientists to understand how different parts of the human brain "connect" -- and to turn this information into a "brain atlas."
Brain researchers already know that autism and schizophrenia are not localized disorders ––there is no one place in the brain they can be found. ...
2010-09-08
LOS ANGELES (September 7, 2010) – The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and will be published in Cancer Prevention Research, on October 5, 2010. Obesity has been associated with an increased incidence of many cancers, including leukemia, but it has been unknown whether the increase in incidence was a direct effect of obesity or associated with genetic, lifestyle, health, or socio-economic factors.
"Given ...
LAST 30 PRESS RELEASES:
[Press-News.org] Acamprosate prevents relapse to drinking in alcoholism
